chr17-82249576-G-A

Variant names:

• chr17-82249576-G-A
• rs60906556
• NM_001893.6:c.912C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_Strong BP6_Very_Strong BP7 BS1 BS2

The NM_001893.6(CSNK1D):​c.912C>T​(p.Ala304Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00186 in 1,558,370 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.0099 (28 hom., cov: 33)
  • Exomes 𝑓: 0.00099 (28 hom.)
• Consequence: CSNK1D NM_001893.6 synonymous
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -3.51

Genes affected

CSNK1D (HGNC:2452): (casein kinase 1 delta) This gene is a member of the casein kinase I (CKI) gene family whose members have been implicated in the control of cytoplasmic and nuclear processes, including DNA replication and repair. The encoded protein may also be involved in the regulation of apoptosis, circadian rhythm, microtubule dynamics, chromosome segregation, and p53-mediated effects on growth. The encoded protein is highly similar to the mouse and rat CK1 delta homologs. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2014]

SLC16A3 (HGNC:10924): (solute carrier family 16 member 3) Lactic acid and pyruvate transport across plasma membranes is catalyzed by members of the proton-linked monocarboxylate transporter (MCT) family, which has been designated solute carrier family-16. Each MCT appears to have slightly different substrate and inhibitor specificities and transport kinetics, which are related to the metabolic requirements of the tissues in which it is found. The MCTs, which include MCT1 (SLC16A1; MIM 600682) and MCT2 (SLC16A7; MIM 603654), are characterized by 12 predicted transmembrane domains (Price et al., 1998 [PubMed 9425115]).[supplied by OMIM, Mar 2008]

ENSG00000280407 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -21 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).
• BP6: Variant 17-82249576-G-A is Benign according to our data. Variant chr17-82249576-G-A is described in ClinVar as [Benign]. Clinvar id is 768923.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BP7: Synonymous conserved (PhyloP=-3.51 with no splicing effect.
• BS1: Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00989 (1507/152328) while in subpopulation AFR AF = 0.0342 (1422/41570). AF 95% confidence interval is 0.0327. There are 28 homozygotes in GnomAd4. There are 684 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
• BS2: High AC in GnomAd4 at 1507 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CSNK1D	NM_001893.6	c.912C>T	p.Ala304Ala	synonymous_variant	Exon 7 of 9	ENST00000314028.11	NP_001884.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CSNK1D	ENST00000314028.11	c.912C>T	p.Ala304Ala	synonymous_variant	Exon 7 of 9	1	NM_001893.6	ENSP00000324464.6

Frequencies

GnomAD3 genomes AF: 0.00987 AC: 1503 AN: 152210 Hom.: 28 Cov.: 33

Gnomad AFR AF: 0.0342

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00438

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00949

Gnomad NFE AF: 0.0000441

Gnomad OTH AF: 0.00574

GnomAD2 exomes AF: 0.00254 AC: 413 AN: 162872 AF XY: 0.00208

Gnomad AFR exome AF: 0.0371

Gnomad AMR exome AF: 0.00200

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.0000152

Gnomad OTH exome AF: 0.000885

GnomAD4 exome AF: 0.000987 AC: 1388 AN: 1406042 Hom.: 28 Cov.: 31 AF XY: 0.000863 AC XY: 600 AN XY: 695090

Gnomad4 AFR exome AF: 0.0342 AC: 1121 AN: 32734

Gnomad4 AMR exome AF: 0.00259 AC: 96 AN: 37078

Gnomad4 ASJ exome AF: 0.00 AC: 0 AN: 25254

Gnomad4 EAS exome AF: 0.00 AC: 0 AN: 37712

Gnomad4 SAS exome AF: 0.0000748 AC: 6 AN: 80206

Gnomad4 FIN exome AF: 0.00 AC: 0 AN: 43124

Gnomad4 NFE exome AF: 0.0000331 AC: 36 AN: 1087398

Gnomad4 Remaining exome AF: 0.00216 AC: 126 AN: 58418

GnomAD4 genome AF: 0.00989 AC: 1507 AN: 152328 Hom.: 28 Cov.: 33 AF XY: 0.00918 AC XY: 684 AN XY: 74494

Gnomad4 AFR AF: 0.0342 AC: 0.0342074 AN: 0.0342074

Gnomad4 AMR AF: 0.00438 AC: 0.0043768 AN: 0.0043768

Gnomad4 ASJ AF: 0.00 AC: 0 AN: 0

Gnomad4 EAS AF: 0.00 AC: 0 AN: 0

Gnomad4 SAS AF: 0.00 AC: 0 AN: 0

Gnomad4 FIN AF: 0.00 AC: 0 AN: 0

Gnomad4 NFE AF: 0.0000441 AC: 0.0000441021 AN: 0.0000441021

Gnomad4 OTH AF: 0.00568 AC: 0.00567644 AN: 0.00567644

Alfa AF: 0.00291 Hom.: 1

Bravo AF: 0.0112

Asia WGS AF: 0.00202 AC: 7 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:2

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Jul 13, 2018

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	0.031
DANN	Benign	0.91
RBP_binding_hub_radar		0.92
RBP_regulation_power_radar		2.6
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs60906556; hg19: chr17-80207452;